Authors
Loading...
Methodological study demonstrates robust group sequential supremum logrank tests under nonproportional hazards, suggesting improved power and early stopping in oncology trials.
Boher et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: